Abstract
The evolution of ovarian cancer will highly depend on platinum sensitivity or resistance. In an attempt to better understand this mechanism of resistance, we combined laser microdissection (LMD) of ovarian tumor cells with mass spectrometric techniques. To obtain disease-specific markers we isolated ovarian tumor cells with LMD without contamination of surrounding cells. Proteins were extracted by chemical lysis and subsequent peptide and protein information was gathered using surface-enhanced laser desorption/ionization-time of flight mass spectrometry.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Heintz APM, Odicino F, Maisonneuve P, Quinn MA, Benedet JL and Creasman WT et al. (2006) Carcinoma of the ovary. FIGO 6th Annual Report on the Results of Treatment in Gynaecological Cancer. Int J Gynaecol Obstet 95 (suppl. 1), S161–192.
Martin LP, Hamilton TC, Schilder RJ. (2008) Platinum resistance: the role of DNA repair pathways. Clin Cancer Res 14,1291–1295.
Cadron I, Van Gorp T, Timmerman D, Amant F, Waelkens E, Vergote I. (2009) Application of proteomics in ovarian cancer: which sample should be used? Gynecol Oncol 115,497–503.
Yan XD, Pan LY, Yuan Y, Lang JH, Mao N. (2007) Identification of platinum resistant associated proteins through proteomic analysis of human ovarian cancer cells and their platinum resistant sub lines. J Proteome Res 6,772–780.
Stewart JJ, White JT, Yan X, Collins S, Drescher CW, Urban ND, et al. (2006) Proteins associated with cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels. Mol Cell Proteomics 5,433–443.
Chien J, Aletti G, Baldi A, Catalano V, Muretto P, Keeney GL, et al. (2006) Serine proteaseHtrA1 modulates chemotherapy induced cytotoxicity. J Clin Invest 116,1994–2004.
Le Moguen K, Lincet H, Deslandes E, Hubert-Roux M, Lange C, Poulain L, et al. (2006) Comparative proteomic analysis of cisplatin sensitive IGROV1 ovarian carcinoma cell line and its resistant counterpart IGROV1-R10. Proteomics 6,5183–5192.
Song J, Shih IeM, Salani R, Chan DW, Zhang Z. (2007) Annexin XI is associated with cisplatin resistance and related to tumor recurrence in ovarian cancer patients. Clin Cancer Res 13, 6842–6849.
Cadron I, Van Gorp T, Amant F, Vergote I, Moerman Ph, Waelkens E, Daemen A, Van de Plas R, De Moor B, Zeillinger R. (2009) The use of laser microdissection and SELDI-TOF MS in ovarian cancer tissue to identify protein profiles. Anticancer Res. 29, 1039–1045.
Schutze K, Clement-Sengewald A, Catch and move-cut or fuse. Nature 1994; 368:667–669.
Schultze K, Lahr G, Burgemeister R. (2000) The force of focused light in different areas of cell and molecular biology. J Mol Med 78, B21.
Melle C, Ernst G,Schimmel B, Bleul A, Thieme H, Kaufmann R, Mothes H, Settmacher U, Claussen U, Halbhuber KJ, Von Eggeling F. (2005) Discovery and identification of alfa defnsins as low abundant tumor derived serum markers in colorectal cancer. Gastroenterology 129, 66–73.
Diaz JL, Cazares LH, Corica A, Semmes OJ. (2004) Selective capture of prostatic basal cells and secretory epitheial cells for proteomic and genomic analysis. Urologic Oncology 329–336.
Kwapiszewska G, Meyer M, Bogumil R, Bohle RM, Seeger W, Weissmann N, Fink L. (2004) Identification of proteins in laser microdissected small cell numbers by SELDI-TOF and Tandem MS, BMC Biotechnology 4, 30.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Cadron, I., Van Gorp, T., Moerman, P., Waelkens, E., Vergote, I. (2011). Proteomic Analysis of Laser Microdissected Ovarian Cancer Tissue with SELDI-TOF MS. In: Murray, G. (eds) Laser Capture Microdissection. Methods in Molecular Biology, vol 755. Humana Press. https://doi.org/10.1007/978-1-61779-163-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-61779-163-5_12
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-61779-162-8
Online ISBN: 978-1-61779-163-5
eBook Packages: Springer Protocols